GeoVax Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress

Ads

You May Also Like

ExCellThera announces results of clinical trial using ECT-001 for blood cancers

MONTREAL, Dec. 04, 2018 (GLOBE NEWSWIRE) -- ExCellThera Inc., a biotechnology company delivering molecules ...

Cellceutix Provides Update on Developing p53 Drug Candidate Kevetrin as an Oral Anti-Cancer Agent

BEVERLY, Mass., March 03, 2017 (GLOBE NEWSWIRE) -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), a ...